Objective: To examine caloric intake, dietary composition, and body mass index (BMI) in participants in the Prospective Huntington At Risk Observational Study (PHAROS).
Individuals who have Huntington disease (HD) have lower body mass index (BMI) than agematched controls, 1-5 and these differences increase as HD advances. 1, 3 Weight loss of Ն1 kg/year was associated with more severe motor impairment and increasingly severe chorea in 927 HD cases followed for a mean of 3.4 years, while weight gain was more common in those with shorter disease duration (0 -2 years). 2 Weight loss in HD may be multifactorial and related to decreased caloric intake from dysphagia, increased energy expenditure due to physical activity (e.g., chorea and dystonia), 6, 7 or a systemic metabolic defect leading to a hypermetabolic state. 8, 9 In 2 studies 6,7 that examined 24-hour energy expenditure and physical activity using indirect calorimetry, total energy expenditure was 11%-14% higher in early to mid-stage HD cases compared with controls and was attributed to increased physical activity during waking hours. Similar studies have not been performed in pre-manifest HD. A study using a semiquantitative, open-ended questionnaire showed significantly higher daily caloric intake and lower BMI in 15 presymptomatic HD cases compared to 21 controls. 8 We assessed the relationship between BMI and diet by administering a semiquantitative food frequency questionnaire (FFQ) 10, 11 to individuals participating in the Prospective Huntington At Risk Observational Study (PHAROS). 12 Our aims were to compare participants with and without expanded CAG to determine 1) whether there were differences in macronutrient intake (protein, carbohydrate, fat), total caloric intake, and BMI, and 2) the relationship between CAG repeat length, BMI, and caloric intake.
METHODS Subjects. All research participants were enrolled in PHAROS between July 1999 and January 2004. 12 Institutional review boards at all participating sites approved the protocols and consent procedures. The aim of PHAROS is to identify the earliest clinical features with the highest specificity that predict manifest HD. At baseline, participants were between 26 and 55 years of age, and at risk for HD by virtue of having an affected parent or sibling. All opted to remain unaware of their HD gene carrier status at the time of enrollment. Details of the baseline assessment of these 1,001 individuals and blinding procedures have been published. 12 A medical history, physical examination, and weight were obtained at each visit. Visits were scheduled every 9 months. Blood was obtained at baseline to measure the trinucleotide expansion (CAG n ) of the HD gene. The central tenet of the PHAROS study stipulates that neither research participants, investigators, nor anyone else will ever be informed of the individual genetic research data. At each assessment, an independent rater at each site performed the motor component of the Unified Huntington's Disease Rating Scale (UHDRS) and assigned a level of diagnostic confidence of HD based solely on this motor examination. A rating of 4 indicated Ն99% confidence of clinically definite HD based on the presence of an unequivocal unexplained extrapyramidal movement disorder. This rating has been shown to have good reliability. 13 Dietary assessment. A total of 675 individuals initially completed the National Cancer Institute FFQ, which has been shown to be reliable and valid. 11 The FFQ was administered, on average, 30 months after baseline examination. Twenty-three individuals were excluded from the analyses presented here because they were identified as having clinically definite HD prior to or at the time of the FFQ, or because they were missing CAG n data. The analyses focus on this first dietary assessment and the BMI at that visit, or the closest visit if the FFQ was not completed at the visit. The closest visit was defined as 180 days prior to the FFQ or within 14 days following the FFQ. Seventy-nine percent of subjects completed the FFQ within 2 days of a visit, and 95% of subjects had a visit that fell within the specified window.
Statistical analyses.
All statistical analyses were conducted by the HSG Biostatistics Center at the University of Rochester using SAS v9. PHAROS baseline measures in individuals who completed the FFQ were compared with those who did not using t tests and 2 tests as appropriate. Demographic characteristics and summary measures from the FFQ were compared in the CAG Ͻ37 (nonexpanded) and CAG Ն37 (expanded) groups 12 using t tests and 2 tests. Macronutrient intake (protein, carbohydrate, fat) was calculated from the FFQ. BMI and summary measures from the FFQ, including caloric intake and macronutrient categories, were divided into quartiles based on the entire sample, and the distribution of individuals with CAG Ͻ37 and CAG Ն37 within these quartiles was compared using Mantel-Haenszel tests for trend.
In individuals whose weight is stable, caloric intake (measured in kcal) should equal total energy expenditure (TEE). TEE is based on basal energy expenditure (BEE), the thermic energy of food, and physical activity. TEE is measured by indirect calorimetry. In this study, because indirect calorimetry was not performed, we considered the caloric intake an estimate of TEE. BEE was calculated for each individual using the Harris Benedict equation. 14 Male BEE equals 66 ϩ 13.7 (weight in kg) ϩ 5 (height in cm) Ϫ 6.8 (age in years), and female BEE equals 65 ϩ 9.6 (weight in kg) ϩ 1.8 (height in cm) Ϫ 4.7 (age in years). TEE minus BEE in a weight-stable individual is a measure of physical activity; large differences suggest that a greater amount of energy is expended in physical activity rather than basal metabolism, digestion, or heat production. Among those who completed the FFQ, the mean (SD) of the change in weight between the FFQ and the following visit (mean 325 days) was 0.50 kg (4.68), p ϭ 0.01. While this small increase in weight represents a significant difference in this large sample, the mean weight gain in kg for those with CAG Ͻ37 was 0.65 (SE 0.23) ( p Ͻ 0.05) and among those with CAG Ն37 was 0.20 (SE 0.36); this difference was not significant. TEE-BEE will be referred to as estimated physical activity.
Logistic regression models were used to examine the relationship of BMI and dietary measures (macronutrient intake, total energy intake, BEE, and estimated physical activity) to genetic status (CAG Ͻ37 or CAG Ն37) as the outcome. The dietary measures and BMI were defined by quartiles, with the lowest quartile (quartile 1) serving as the reference. Covariates included age (Ն50, 40 -49, Ͻ40 years), gender, and education (Ͼ16, 13-16, Յ12 years). In separate analyses total motor score dichotomized (Յ1, Ͼ1 units) and chorea score (0, Ͼ0) were included as additional covariates.
Finally, CAG repeat length was correlated with BMI, caloric intake, and estimated physical activity in the CAG Ն37 group with multiple linear regression using the quartile values (1, 2, 3, 4) as continuous variables and adjusting for age, gender, and education. In addition, for BMI we adjusted for caloric intake, and for caloric intake we adjusted for BMI. We also calculated the predicted 5-year probability of clinical onset of HD 15,16 using a CAG-based model developed using data from close to 3,000 individuals. The above linear regression was carried out using the predicted 5-year probability of onset as an outcome variable.
All analyses were repeated, excluding all individuals who had more than 10 items missing on the dietary interview, and women with caloric intake Ͻ550 kcal or Ͼ3,500 kcal per day, and men with caloric intake Ͻ650 kcal or Ͼ4,000 kcal per day.
RESULTS
The PHAROS study enrolled 1,001 research participants. The FFQ was completed by 675 individuals (441 CAG Ͻ37 and 233 CAG Ն37 [1 missing CAG]), but was not completed by 326 individuals. The FFQ was completed on average 30 months after the baseline visit (range 0 -74 months). Completers and noncompleters did not significantly differ in age, gender, ethnicity, or percentage with expanded CAG repeat (data not shown). Noncompleters had significantly fewer years of education (14.4 Seven individuals who completed the FFQ were rated a 4 (meets clinical criteria for HD) at the time of their baseline examination and were excluded from this analysis. An additional 15 individuals were rated a 4 prior to or at the time of the FFQ and were excluded from the analysis, for a total of 22 individuals. One individual who did not have CAG repeat data was also excluded.
Demographic characteristics and summary measures from the FFQ in 435 individuals with CAG Ͻ37 and the 217 individuals with CAG Ն37 who completed the FFQ (n ϭ 652), had CAG n data, and did not meet clinical criteria for HD are presented in table 1. The total UHDRS motor score and the chorea score were significantly higher among those with an expanded CAG repeat. We examined the difference between TEE (estimated using total caloric intake) and BEE as a measure of estimated physical activity. Due to the presence of outliers for the dietary variables, the distributions of these variables by quartile were compared for individuals with CAG Ͻ37 and CAG Ն37 (table 2). Caloric intake was significantly higher in the CAG Ն37 group ( p for trend ϭ 0.01). BMI and estimated physical activity were marginally different, while BEE did not differ significantly. Carbohydrate intake was significantly higher in the expanded CAG repeat group ( p for trend ϭ 0.02).
Unadjusted and adjusted odds ratios (OR) are presented for the relationship between caloric intake, BMI, and estimated physical activity, with group membership (CAG Ͻ37 or CAG Ն37) as the outcome (table 3) . In both unadjusted and adjusted analyses, the odds of membership in the CAG Ն37 group were increased approximately twofold for each quartile (second, third, and fourth) of caloric intake compared with the lowest quartile (first) (reference) ( p for trend 0.05). The highest odds were for the second quartile compared to the reference, and the odds decreased with increasing caloric intake (figure). When total motor score was included as a covariate, this relationship was attenuated only in the highest quartile (fourth). Higher estimated physical activity was associated with an increased odds of membership in the CAG Ն37 group after adjustment for age, gender, and education (p for trend 0.02). When total motor score from the UHDRS was included as a covariate, the relationship between total estimated physical activity and group membership was attenuated, as would be expected since total motor score is a measure of physical activity. The association of BMI and genetic status did not reach significance. Adjusting for the dichotomized chorea score (0 vs Ͼ0) produced results that were similar to those produced by adjustment of the dichotomized motor score (data not shown).
When all analyses were repeated excluding individuals who had 10 or more missing data points or had extreme caloric intakes, the logistic regression results were similar (data not shown).
Macronutrient assessment. There was no difference in the distribution of macronutrients (protein, carbohydrates, and fat) between the CAG Ն37 and CAG Ͻ37 groups after adjustment for age, gender, education, and total caloric intake (data not shown).
Relationship between CAG repeat length, BMI, kcal,
and estimated physical activity. For the expanded CAG repeat length group (CAG Ն37), caloric intake was significantly correlated with both CAG repeat length and estimated 5-year probability of HD onset after adjustment for age, gender, education, and BMI (table 4). There was an estimated 0.26 CAG unit increase for each unit increase in kcal quartile. Similarly, we estimate an increase of 2.4% in the 5-year probability of onset for each unit increase in kcal quartile. BMI was not correlated with CAG repeat length after adjustment for age, gender, education, and caloric intake.
DISCUSSION This is the largest study of dietary factors in individuals at risk for HD who were unaware of their genetic status. Individuals with expanded CAG (Ն37) reported a similar caloric intake yet had a lower BMI compared with those without expanded CAG (Ͻ37). In the CAG Ն37 group, higher caloric intake was related to both higher CAG repeat length and higher 5-year probability of onset of HD after adjustment for relevant covariates. This linear relationship was not demonstrated with BMI. We did not find any difference in macronutrient intake after adjustment for covariates in the CAG Ն37 group compared to CAG Ͻ37. One small study that utilized a 3-day diary reported increased carbohydrate intake among individuals with an expanded CAG repeat, 5 as we also report in unadjusted analysis (table 1) . Longitudinal studies will be helpful in determining whether there are changes in macronutrients and energy requirements as some individuals in this cohort develop HD.
Weight loss among HD gene carriers may be due to excessive involuntary movements, difficulty with swallowing, or malabsorption. We cannot exclude the possibility of increased energy expenditure secondary to movement; however, we believe that we considerably reduced the possibility that increased energy expenditure would be due solely to subtle involuntary movement by eliminating 22 individuals who received a clinical research diagnosis of HD at baseline or at any time up to the administration of the FFQ. In a study of 517 patients with early stage HD, BMI decrease over a 3-year period was related to expanded CAG repeat length, but not to any specific component of the UHDRS (motor, cognitive, or behavioral). 18 When we adjusted for total motor score and chorea alone, the relationship between caloric intake and membership in the CAG Ն37 category was diminished but did not disappear.
Using the Huntington Study Group database of manifest HD cases compared to age-matched controls (1:5), we reported significantly lower BMI in 361 symptomatic HD cases at the earliest stage of the illness (Total Functional Capacity Ͼ11 [0 -13; 13 normal], chorea or dystonia score Յ2, and duration Ͻ4 years), suggesting that differences in body composition may occur early among symptomatic individuals. 4 BMI was lower than reported in the current study of pre-manifest individuals, although scores on the chorea and dystonia scores were similar, suggesting that the individuals in the previous study were more advanced. Because the participants in this study were not aware of their genetic status, any increase in caloric intake could not be attributed to that information. In addition, if swallowing difficulty accounted for weight loss, one might expect a decrease rather than an increase in caloric intake in the CAG Ն37 group.
Limitations of the current study include the fact that the dietary assessments were self reports, and there was no opportunity to validate dietary intake. In addition, all surveys were filled out privately. There were no corrections or queries for missing data. One-third of the participants did not complete the FFQ. These individuals performed significantly worse on the cognitive portion of the UHDRS and reported more depressive symptoms and functional complaints; however, the proportion of carriers of an expanded CAG repeat did not significantly differ be-tween those who completed the survey and those who did not. We did not have specific questions about dysphagia. We were only able to approximate TEE because indirect calorimetry was not obtained. We also had no measure of reported physical activity to determine to what extent the TEE was due to physical activity. Indirect calorimetry studies and precise measurement of physical activity in this population of pre-manifest individuals would be valuable. These data add to the converging evidence from both murine and human HD of a heightened metabolic (procatabolic) state that may occur prior to the development of the overt motor manifestations of HD. 9, 19, 20 A metabolomic (small molecule metabolite) profile consisting of changes in fatty acid breakdown products, increased nucleic acid breakdown, and a dysregulation of amino acid metabolism was associated with a procatabolic state in both murine models and human HD compared with controls. 20 In murine models and humans, the metabolic signatures differed between the pre-manifest and clinically manifest states, suggesting a change with disease progression. A study of 15 pre-manifest HD cases using 1 H NMR spectroscopy showed that low plasma lev- els of branched-chain amino acids distinguished premanifest HD cases from controls, and these levels were correlated with weight loss and CAG repeat length. 8 Weight loss may predate the motor manifestations in HD transgenic mice (R6/2 and N17182Q). It has been postulated that reduction in HAP-1, which binds more strongly to mutant Huntingtin than normal huntingtin protein and is a feeding stimulatory protein, may be linked to weight loss in HD. 9 HAP-1 knockout mice show both weight loss and hypothalamic degeneration. 21 Whether changes in TEE and BMI are strictly pre-manifest or occur in the setting of subtly emerging illness is unclear. In Parkinson disease (PD), weight loss in the setting of increased caloric intake occurred 2 to 4 years prior to diagnosis 22 and increases with disease progression. No difference in BMI was seen among men who participated in the Harvard Alumni study who developed incident PD (n ϭ 106) when BMI was examined prior to college and at baseline assessment; however, those who lost 0.5 kg per decade between college and baseline were at increased risk for development of PD. 23 In another population-based study, BMI Ͼ23 between ages 25-59 was associated with a twofold increased risk of PD. 24 These studies suggest that while high absolute BMI in midlife may be associated with increased risk of PD, reduction in BMI over time may also be a risk for incident PD.
The correlation of caloric intake, but not BMI, with higher CAG repeat length and increased estimated probability of onset of HD within 5 years suggests that individuals may be consuming more calories to maintain their weight during the premanifest period but eventually may not be able to compensate and preserve energy balance. Early to mid-stage HD cases provided with sufficient caloric intake in a controlled setting were capable of maintaining a positive energy balance. However, under free living conditions, repeated 24-hour dietary re-calls were more variable in these patients with HD than controls and variability increased with disease stage (Total Functional Capacity), 7 which may explain why some patients with HD lose weight. The relationship between dietary intake and measures of disease severity indicators is expected to be clarified with longitudinal assessment of the PHAROS cohort.
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